home / stock / dgnof / dgnof news


DGNOF News and Press, Diagnos Inc

Stock Information

Company Name: Diagnos Inc
Stock Symbol: DGNOF
Market: OTC
Website: diagnos.ca

Menu

DGNOF DGNOF Quote DGNOF Short DGNOF News DGNOF Articles DGNOF Message Board
Get DGNOF Alerts

News, Short Squeeze, Breakout and More Instantly...

DGNOF - DIAGNOS celebrates the launch of Labtician's new screening service for diabetic retinopathy in Ontario and renews its distribution agreement

BROSSARD, Quebec, May 21, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through its FL AI RE platform based on Artificial Intelligence ( AI ), is ...

DGNOF - DIAGNOS to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024

BROSSARD, Quebec, May 06, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health issues, in collaboration with ETS, École de Technologie ...

DGNOF - DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification

BROSSARD, Quebec, April 16, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health issues, announces today that it is working on getting new H...

DGNOF - AI & Technology Hybrid Investor Conference Agenda: Presentations Now Available for Online Viewing

NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the AI & Technology Hybrid Virtual Investor Conference presented by Water Tower Research held April 10 th and April 11 th...

DGNOF - AI & Technology Hybrid Investor Conference Presented by Water Tower Research Agenda Announced for April 10 and 11

NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the AI & Technology Hybrid Investor Conference presented by Water Tower Research to be held April 10 and 11. The two-day conference wil...

DGNOF - DIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11th

MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (ADK TSX: OTCQB: DGNOF), based in Montreal, Canada, focused on Artificial Intelligence for the medical market, today announced that André Larente, CEO, will present live at the AI & Technology Hybrid Virtual Investor Conferenc...

DGNOF - DIAGNOS inc. to Present at the AI & Technology Hybrid Investor Conference April 11th

MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) -- DIAGNOS inc. (ADK TSX: OTCQB: DGNOF), based in Montreal, Canada, focused on Artificial Intelligence for the medical market, today announced that Andre Larente, CEO, will present live at the AI & Technology Hybrid Virtual Investor Conferenc...

DGNOF - DIAGNOS Welcomes Dr. Philippe Couillard to its Board of Directors

BROSSARD, Quebec, April 02, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence ( AI ) technologies, is pleased to announce the appointment o...

DGNOF - DIAGNOS Announces Closing of Second and Final Tranche of Private Placement

BROSSARD, Quebec, March 22, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence ( AI ) technologies, announces th...

DGNOF - DIAGNOS Welcomes Mr. Michael Braeuel to its Board of Directors

BROSSARD, Quebec, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence ( AI ) technologies, is pleased to announce the appointment of...

Next 10